The XV. Banff conference for allograft pathology was held in conjunction with the annual
meeting of the American Society for Histocompatibility and Immunogenetics in Pittsburgh, PA (…

The XIII Banff meeting, held in conjunction the Canadian Society of Transplantation in
Vancouver, Canada, reviewed the clinical impact of updates of C4d-negative antibody-mediated …

In both atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (C3G) complement
plays a primary role in disease pathogenesis. Herein we report the outcome of a 2015 …

… MD 6 ; Horsfield, Catherine MD 3 ; Loupy, Alexandre MD 7 ; Mengel, Michael MD 8 ;
Perkowska-Ptasińska, Agnieszka MD 9 ; Rabant, Marion MD, PhD 10 ; Racusen, Lorraine C …

Kidney allograft rejection can occur in clinically stable patients, but long-term significance is
unknown. We determined whether early recognition of subclinical rejection has long-term …

Objectives To assess the long term outcomes of transplantation using expanded criteria
donors (ECD; donors aged ≥60 years or aged 50-59 years with vascular comorbidities) and …

For three decades, the international Banff classification has been the gold standard for
kidney allograft rejection diagnosis, but this system has become complex over time with the …

Microbial nucleic acid recognition serves as the major stimulus to an antiviral response,
implying a requirement to limit the misrepresentation of self nucleic acids as non-self and the …

In hemolytic diseases, such as sickle cell disease (SCD), intravascular hemolysis results in
the release of hemoglobin, heme, and heme-loaded membrane microvesicles in the …

Urinary levels of CXC motif chemokine 9 (CXCL9) and CXCL10 can noninvasively diagnose
T cell–mediated rejection (TCMR) of renal allografts. However, performance of these …